Loading patent…
OwnerThomas CROUZIER, Ulrike SCHIMPFinventors
Estimating the term…
The disclosure relates to a vaginal contraceptive composition comprising one or more active ingredients and at least one formulation compound selected from a physiological acceptable gelling agent or a physiological acceptable carrier, wherein at least one of the one or more active ingredients is a mucoadhesive polymer, wherein said mucoadhesive polymer has a molecular weight between 90,000 Da and 350,000 Da, wherein said mucoadhesive polymer consists of a plurality of monomer units linked to each other via ether bonds, ester bonds, amide bonds, or combinations hereof, wherein said monomer units are selected from C6 sugars, amino-functionalised C6 sugars, amino acids, or combinations hereof, and wherein at least 50% of the monomer units comprise at least one amino group. The disclosure further relates to a use of a vaginal contraceptive composition, a vaginal contraceptive composition for use in therapy, a vaginal contraceptive composition for use as a contraceptive or contraceptive agent and a vaginal contraceptive composition for use in birth control or birth control therapy.
A vaginal contraceptive composition comprising one or more active ingredients and at least one formulation compound selected from a physiological acceptable gelling agent or a physiological acceptable carrier, wherein at least one of the one or more active ingredients is a mucoadhesive polymer, wherein said mucoadhesive polymer has a molecular weight between 90,000 Da and 350,000 Da, wherein said mucoadhesive polymer consists of a plurality of monomer units linked to each other via ether bonds, ester bonds, amide bonds, or combinations hereof, wherein said monomer units are selected from C6 sugars, amino-functionalised C6 sugars, amino acids, or combinations hereof, and wherein at least 50% of the monomer units comprise at least one amino group.
13-15. (canceled)
Dependencies are inferred from the claim text.